ADAR1 Capital Management, LLC - 21 Aug 2025 SCHEDULE 13D/A Report for Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

Filing Manager
ADAR1 Capital Management, LLC
Reporting Manager
ADAR1 Capital Management, LLC
Security
Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KROS
Shares outstanding
40.6M shares
Disclosed Ownership
5.39M shares
Ownership
13.3%
Form type
SCHEDULE 13D/A
Filing time
21 Aug 2025, 16:15:33 UTC
Date of event
21 Aug 2025
Previous filing
12 May 2025
Next filing
15 Oct 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 13.27% 5.39M 5.39M 0 /s/ Daniel Schneeberger Daniel Schneeberger, Manager 0001940272
ADAR1 Capital Management GP, LLC 11.44% 4.65M 4.65M 0 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
Daniel Schneeberger 13.27% 5.39M 5.39M 0 /s/ Daniel Schneeberger Daniel Schneeberger